Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00224198 · ClinicalTrials.gov registry record
Evaluation of the Lungs of Individuals With Lung Disease
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 196
- Enrollment target
NCT00224198 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 196 participants.
The verdict
NCT00224198 has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 196 participants
- Enrollment target
Study Summary
The purpose of this protocol is to obtain biologic materials from the blood and lungs from patients with lung disease in order to develop an understanding of the etiology and pathogenesis of these disorders. General admission criteria for this project will require at least one of the following: (1) symptoms consistent with pulmonary disease; (2) chest X-ray consistent with lung disease; (3) pulmonary function tests consistent with lung disease; (4) lung biopsy consistent with lung disease; (5) family history of lung disease; and (6) patients with diseases of organs with known association with lung disease.
Interventions
- PROCEDURE Lung Disease
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 196 participants |
| Start Date | 2004-01 |
| Est. Completion | 2012-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00224198
The ClinicalTrials.gov registry entry for NCT00224198 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 196 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lung Disease is the first listed.
NCT00224198 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00224198 about?
NCT00224198 is a clinical study titled "Evaluation of the Lungs of Individuals With Lung Disease". The purpose of this protocol is to obtain biologic materials from the blood and lungs from patients with lung disease in order to develop an understanding of the etiology and pathogenesis of these disorders. General admission criteria for this project will require at least one of the following: (1) ...
What is the current status of trial NCT00224198?
This trial is currently completed. The enrollment target is 196 participants. The study started on 2004-01. Estimated completion is 2012-09.
What interventions are being tested in trial NCT00224198?
The interventions under investigation include: Lung Disease (PROCEDURE).
Who is sponsoring clinical trial NCT00224198?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.